Prediction of atherosclerotic disease progression using LDL transport modelling: a serial computed tomographic

Antonis Sakellarios1, Christos V Bourantas2,3, Stella-Lida Papadopoulou4

  • 1Unit of Medical Technology and Intelligent Information Systems, Department of Materials Science and Engineering, University of Ioannina, Ioannina, Greece.

Insights

Low-density lipoprotein (LDL) transport simulation in CTCA-reconstructed arteries predicts coronary artery disease progression. This method, combined with plaque characteristics, offers moderate accuracy in identifying segments with significant plaque burden increase.

Area of Science:

  • Cardiovascular Imaging and Intervention
  • Biomedical Engineering
  • Translational Medicine

Background:

  • Coronary artery disease (CAD) progression is a major cause of cardiovascular events.
  • Predicting vulnerable coronary segments is crucial for timely intervention.
  • Computed tomography coronary angiography (CTCA) provides detailed anatomical information.

Purpose of the Study:

  • To evaluate the efficacy of low-density lipoprotein (LDL) transport simulation in CTCA-derived arterial models.
  • To predict coronary segments prone to significant atherosclerotic disease progression.
  • To compare LDL transport simulation with endothelial shear stress (ESS) in predicting disease progression.

Main Methods:

  • Reconstruction of coronary arteries from CTCA data of 32 patients with acute coronary events.
  • Performance of LDL transport simulation in baseline arterial models.
  • Analysis of LDL concentration, plaque burden, plaque area, and ESS as predictors of disease progression over 3 years.

Main Results:

  • High LDL concentration, plaque burden, and plaque area were independent predictors of substantial disease progression.
  • LDL concentration was a more accurate predictor than ESS (65.1% vs. 62.5% accuracy).
  • ESS was a univariate predictor but not independent when LDL concentration was included.

Conclusions:

  • LDL transport modeling, combined with CTCA-derived atheroma characteristics, shows moderate accuracy in predicting mid-term plaque burden increase.
  • LDL transport simulation appears to be a superior predictor of atherosclerotic disease progression compared to ESS.
  • This approach aids in identifying coronary segments at risk for significant plaque progression.
Abstract

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.9K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
576
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance01:07

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance

Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
370
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
943
Inflammation01:38

Inflammation

Overview
64.0K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.6K